SCHEMBL9957790

SCHEMBL9957790

C1=C(CNCCc2cccnc2)OCO1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 1/20 0.47
CHRM2 P08172 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
CHRNA7 P36544 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.39
CYP2A6 P11509 1/20 0.39
NOS1 P29475 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16606308 0.77 CYP1A2 (0.74) HTR5ACHRM2CYP1A2CYP2D6HTR2A
SCHEMBL16606311 0.75 CYP1A2 (0.63) HTR5ACHRM2CYP1A2CYP2D6CHRNA7
SCHEMBL1238008 0.73 CYP1A2 (0.61) HTR5ACHRM2CYP1A2CYP2D6HTR2A
SCHEMBL7235869 0.71 CYP1A2 (0.69) CHRM2CYP1A2CYP2D6ALDH1A1GAA
SCHEMBL7703948 0.71 MEN1 (0.45) CHRM2GAAMAPTMEN1KMT2A
SCHEMBL9957788 0.71 FDPS (0.39) CYP1A2CYP2D6CHRNA7ALDH1A1KDM4E
SCHEMBL1238227 0.70 HTT (0.76) HTR5ACHRM2CYP1A2CYP2D6HTR2A
Hydrochloric Acid SCHEMBL30115033 0.70 CYP1A2 (0.67) CHRM2CYP1A2CYP2D6ALDH1A1GAA
SCHEMBL27569236 0.70 CYP1A2 (0.56) HTR5ACHRM2CYP1A2CYP2D6ALDH1A1
SCHEMBL10282657 0.70 TDP1 (0.58) HTR5ACHRM2CYP1A2CYP2D6CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2467364-A2 NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION Otsuka Pharmaceutical Co., Ltd. (JP) 2012-06-27 EP disclosed